SCHEMBL8713810

SCHEMBL8713810

CCCCCc1ccc(C2c3c(C)c(N)c(C)c(C)c3OC2(C)C)cc1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LPL P06858 4/20 0.39
LIPG Q9Y5X9 4/20 0.39
SPHK1 Q9NYA1 4/20 0.38
CNR2 P34972 2/20 0.37
CNR1 P21554 1/20 0.37
HTR2A P28223 1/20 0.36
SKP2 Q13309 1/20 0.34
ESR1 P03372 2/20 0.33
ADRA2A P08913 2/20 0.33
ADORA3 P0DMS8 2/20 0.33
TACR2 P21452 2/20 0.33
SLC6A2 P23975 2/20 0.33
SLC6A4 P31645 2/20 0.33
SLC6A3 Q01959 2/20 0.33
KDM4E B2RXH2 1/20 0.33
ALDH1A1 P00352 1/20 0.33
LMNA P02545 1/20 0.33
SHBG P04278 1/20 0.33
TP53 P04637 1/20 0.33
CYP3A4 P08684 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9665976 0.88 ESR1 (0.42) LPLLIPGSPHK1HTR2AESR1
SCHEMBL8712967 0.83 LPL (0.41) LPLLIPGSPHK1CNR2CNR1
SCHEMBL3602073 0.76
SCHEMBL9668185 0.66
SCHEMBL9665225 0.66 CYP19A1 (0.30)
SCHEMBL10568240 0.62 ESR1 (0.73) LPLLIPGHTR2AESR1ADRA2A
SCHEMBL181089 0.62 ESR1 (0.73) LPLLIPGHTR2AESR1ADRA2A
SCHEMBL109256 0.61 HTR2A (0.72) LPLLIPGHTR2AESR1ADRA2A
SCHEMBL23849704 0.60 ESR1 (0.77) LPLLIPGHTR2AESR1ADRA2A
SCHEMBL1412818 0.60 ESR1 (0.77) LPLLIPGHTR2AESR1ADRA2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5770772-A 4-FORMYLAMINO-2,3,5-TRIMETHYL-1-(2-METHYL-2-PROPENYLOXY) -BENZENE; ARTERIOSCLEROSIS, BRAIN AND CARDIOVASCULAR DISORDERS TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) 1998-06-23 US disclosed
US-5594154-A 5-AMINO-2-BROMOMETHYL-2,4,6,7-TETRAMETHYL-2,3-DIHYDROBENZO(B) FURANS TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) 1997-01-14 US disclosed
US-5478844-A Method of using aminocoumaran derivatives for treating cerebrovascular diseases TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) 1995-12-26 US disclosed
EP-0483772-B1 Aminocoumaran derivatives, their production and use TAKEDA CHEMICAL INDUSTRIES LTD (JP) 1995-09-13 EP disclosed
US-5376681-A Aminocoumaran derivatives, their production and use TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) 1994-12-27 US disclosed
EP-0483772-A1 Aminocoumaran derivatives, their production and use TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) 1992-05-06 EP disclosed